Cure-Although most thought this was a nuisance suit, there was one hurdle of whether PPHM was negligent in validating one last test before releasing the PR. Apparently, the CA is stating this was routine and would have identified the discrepancy. Just bizarre, but may cost us.
Market Data 
Markets 
AI
